Nadine Dreimüller

Nadine Dreimüller

Auto-generated profile, based on publicly available information

Nadine Dreimüller

Universitätsmedizin Mainz

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2017 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
SWStefanie Wagner
Stefanie Wagner
AEAlice Engel
Alice Engel
JEJan Engelmann
Jan Engelmann
DHDavid P Herzog
David P Herzog
NDNadine Dreimüller
Nadine Dreimüller
KLKlaus Lieb
Klaus Lieb

1 September 2019 in Journal of Affective Disorders
Verified
Journal Article
Closed access
NDNadine Dreimüller
Nadine Dreimüller
KLKlaus Lieb
Klaus Lieb
ATAndré Tadić
André Tadić
JEJan Engelmann
Jan Engelmann
DWDaniel Wollschläger
Daniel Wollschläger
SWStefanie Wagner
Stefanie Wagner

6 August 2021 in Metabolites
Verified
Journal Article
Open access
PDF file
MLMoritz Losacker
Moritz Losacker
MKMichael Kraemer
Michael Kraemer
APAlexandra Philipsen
Alexandra Philipsen
KDKristina Duecker
Kristina Duecker
NDNadine Dreimueller
Nadine Dreimueller
CHCornelius Hess
Cornelius Hess
In forensic toxicology, amphetamine intoxications represent one of the most common case groups and present difficult questions for toxicologists. Estimating the time of consumption and the current influence of the stimulant is particularly difficult when only total amphetamine concentrations are considered. Stereoselective analysis and the consideration of metabolites can provide valuable information to facilitate interpretation. An enantioselective liquid chromatography−tandem mass spectrometry (LC-MS/MS) method for detection of amphetamine, norephedrine and 4-hydroxyamphetamine was developed. Validation showed satisfactory selectivity, sensitivity, linearity (0.5–250 ng/mL), precision and accuracy for all enantiomers. The method was applied to a collective of 425 forensic serum samples and 30 serum samples from psychiatric inpatients stating their last time of amphetamine consumption. Norephedrine and 4-hydroxyamphetamine were detected more frequently at higher amphetamine concentrations and at lower amphetamine (R)/(S) concentration ratios, possibly indicating recent consumption. Mean (R)/(S) ratio of amphetamine was 1.14, whereas higher ratios (mean 1.36) were found for amphetamine concentrations below 100 ng/mL. The (R)/(S) ratios of psychiatric inpatients significantly correlated with the reported time intervals to last consumption. The use of amphetamine (R)/(S) ratios and the simultaneous detection of metabolites are promising factors that can facilitate estimation of consumption time and current impairment.

14 January 2019 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
NDNadine Dreimüller
Nadine Dreimüller
SWStefanie Wagner
Stefanie Wagner
AEAlice Engel
Alice Engel
DBDieter F. Braus
Dieter F. Braus
SRSibylle C. Roll
Sibylle C. Roll
KLKlaus Lieb
Klaus Lieb
Patients with Major Depressive Disorder (MDD) who are non-improvers after two weeks of antidepressant treatment have a high risk of treatment failure. Recently, we did not find differences in outcomes in non-improvers randomized to an early medication change (EMC) strategy compared to treatment as usual (TAU). This secondary analysis investigated possible predictors of higher remission rates in the EMC strategy. Of 192 non-improvers (i.e. decrease of ≤20% on the HAMD-17 depression scale) after a two-week treatment with escitalopram, n = 97 were randomized to EMC (immediate switch to high doses of venlafaxine XR) and n = 95 to TAU (continued escitalopram until day 28 with non-responders switched to venlafaxine XR). We first analyzed patient characteristics, psychopathological features and subtypes of MDD by logistic regression analyses as possible predictors of remission rates. In a second investigation, we analyzed the predictors, which showed a significant association in the first analysis before Bonferroni-Holm correction by chi-squared tests separated for treatment groups. All analyses were corrected by Bonferroni-Holm method. The first analyses yielded no statistically significant results after correction for multiple testing. In the second analyses, however, patients with prior medication at study entry showed higher remission rates in EMC than in TAU (24.2% versus 8.6%, p = 0.017; Bonferroni-Holm corrected significance level: p = 0.025.). Furthermore, patients with a recurrent course of MDD benefited less from treatment as usual (p = 0.009; Bonferroni-Holm corrected significance level: p = 0.025). Age, sex, age of onset, psychiatric or somatic comorbidities, and other subtypes of MDD did not predict remission rates. Although in our first analysis we found statistically non-significant results, the second analysis showed significant differences in remission rates between patients with or without previous medication and in patients with recurrent MDD or the first depressive episode. It would therefore be valuable to examine in larger and prospective studies whether remission rates can be increased by quick escalation of treatment in certain subgroups of patients. Promising subgroups to be tested are patients who were previously medicated, and who show a recurrent course of MDD. clinicaltrials.gov Identifier: NCT00974155 . Registered at the 10th of September 2009. Retrospectively registered.

2 May 2019 in BMC Medical Education
Verified
Journal Article
Open access
PDF file
NDNadine Dreimüller
Nadine Dreimüller
SSStefan Schenkel
Stefan Schenkel
MSMarlene Stoll
Marlene Stoll
CKCora Koch
Cora Koch
KLKlaus Lieb
Klaus Lieb
JJJana Juenger
Jana Juenger
Performing a psychiatric interview and documenting the recorded findings in the form of a brief psychiatric report is one of the main learning goals in the psychiatric curriculum for medical students. However, observing and assessing students‘ reports is time consuming and there are no objective assessment tools at hand. Thus, we applied an integrative approach for designing a checklist that evaluates clinical performance, as a tool for the assessment of a psychiatric report. A systematic review of the literature yielded no objective instrument for assessing the quality of written reports of psychiatric interviews. We used a 4-step mixed-methods approach to design a checklist as an assessment tool for psychiatric reports: 1. Development of a draft checklist, using literature research and focus group interviews; 2. Pilot testing and subsequent group discussion about modifications resulting from the pilot testing; 3. Creating a scoring system; 4. Testing for interrater-reliability, internal consistency and validity. The final checklist consisted of 36 items with a Cronbach’s alpha of 0.833. Selectivity of items ranged between 0.080 and 0.796. After rater-training, an interrater-reliability of 0.96 (ICC) was achieved. Our approach, which integrated published evidence and the knowledge of domain experts, resulted in a reliable and valid checklist. It offers an objective instrument to measure the ability to document psychiatric interviews. It facilitates a transparent assessment of students’ learning goals with the goal of structural alignment of learning goals and assessment. We discuss ways it may additionally be used to measure the ability to perform a psychiatric interview and supplement other assessment formats.

27 October 2015 in InFo Neurologie + Psychiatrie
Verified
Journal Article
Closed access
PDF file
NDNadine Dreimüller
Nadine Dreimüller